Nexalin Technology, Inc. (NXL) has 24 open-market insider trades by 11 insiders since 2006. The most active filer is David Owens, Chief Medical Officer.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Steven F. Siegel | Exec VPGen Counsel and Secy | — | 1 | $1.5M | 2007-04-04 |
| Dean Bernstein | EVP- Acquisitions/Dispositions | — | 2 | $1.4M | 2007-04-04 |
| John Roche | Exec VP and CFO | — | 1 | $1.3M | 2007-04-04 |
| Norman Gold | Dir | — | 2 | $911K | 2007-04-04 |
| Michael A. Carroll | Exec VPReal Estate Op | — | 1 | $829K | 2007-04-04 |
| Mark White | CEOPres | — | 2 | $218K | 2022-09-16 |
| Leonard Osser | CFO | — | 2 | $160K | 2025-09-29 |
| David Owens | Chief Medical Officer | — | 10 | $35K | 2025-09-29 |
| Carolyn Hamby Shelton | Sr. VP - QualityRegulatory | — | 1 | $13K | 2025-03-12 |
| Alan Kazden | Dir | — | 1 | $10K | 2025-09-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Carolyn Hamby Shelton | Sr. VP - Quality & Regulatory | Buy | $13K | 2025-03-12 |
| David Owens | Chief Medical Officer | Buy | $3K | 2025-02-04 |
| David Owens | Chief Medical Officer | Buy | $3K | 2025-02-04 |
| David Owens | Chief Medical Officer | Buy | $4K | 2025-01-28 |
| David Owens | Chief Medical Officer | Buy | $8K | 2025-01-13 |
| David Owens | Chief Medical Officer | Buy | $1K |
Companies that share insiders with NXL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-10-28 |
| David Owens | Chief Medical Officer | Buy | $950 | 2024-08-13 |
| David Owens | Chief Medical Officer | Buy | $2K | 2024-06-28 |
| David Owens | Chief Medical Officer | Buy | $1K | 2024-06-18 |
| David Owens | Chief Medical Officer | Buy | $2K | 2024-06-10 |
| Leonard Osser | — | Buy | $11K | 2022-09-28 |
| Mark White | President | Buy | $10K | 2022-09-16 |
| Leonard Osser | CFO | Buy | $149K | 2022-09-16 |
| Mark White | CEO & President | Buy | $208K | 2022-09-15 |
| Norman Gold | Director | Sell | $748K | 2007-03-12 |